DIA: Driving Insights to Action
Science:Life Sciences
Telematics has evolved since the first joint HMA/EMA Telematics strategy in 2014. “The vision for EU telematics is an IT collaboration that will deliver cost-effective, efficient, and interoperable services to the European regulators and to its stakeholders,” suggests Bernd Misselwitz, Director and Regional Head, Regulatory Submission Management, Bayer AG (Germany). “Maybe from an IT perspective, it was the technical problem first and business was second; now that you've seen how people want to get value out of it, it's starting to shift where the business problem comes first,” explains Vada A. Perkins, Executive Director, Regulatory Policy & Intelligence at Bayer Pharmaceuticals (Global). Vada and Bernd will help lead the DIA Europe 2020 session Telematics Strategy in the EU: Global & Regional Considerations for 2020-2025.
DIAmond Session 203: “Innovation is Clearly Happening”: Next Generation Collaboration: Transforming the Industry
DIAmond Session 201: International Regulatory Convergence, Collaboration & Cooperation
Executive FDA Leadership Reviews & Previews PDUFA Reauthorization
“Biosimilars have at last come of age in the United States”
Mission, History & Opportunity Attracts New DIA Americas Leadership
Clinical & Real-World Data: Is AI the Missing Link?
TransCelerate Moves Clinical QMS from Vision to Conceptual Framework
Executive Director Shares New CTTI Strategic Plan to Improve Clinical Trials
Who Determines the Price of Medicines – and How?
“An Urgent Imperative Now to Learn Quickly”: DIA 2016 Co-Chair Dr. Gigi Hirsch
Industry-Patient Relations: Culture Change or Culture Shock?
Every Journey Begins with a First Step: DIA Patient Engagement
“Outbreaks are inevitable. Pandemics are preventable.” – DIA 2016 Keynote Speaker Dr. Larry Brilliant
Growing Irrelevancy of Pre- versus Post-Market Divide for EU Medical Devices
Crossroads in Europe: Access from a Market and HTA Perspective
A Visionary Takes the Helm at DIA Europe, Middle East & Africa (DIA EMEA)
Steps to Meet the “Big Quality” Challenge of “Big Data”
Innovation: Can it Span the “Efficacy versus Effectiveness Gap”?
Dr. Kemal Malik Ponders “Is Innovation Always the Answer?”
EMA Senior Medical Officer Explains “Access versus Evidence Tradeoff”
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Ground Truths